The acting head of the Justice Department's civil division, Stuart Delery, said "For far too long, we have heard that the pharmaceutical industry views these settlements merely as the cost of doing business. That is why this adminstration is committed to using every available tool to defeat health care fraud." Glaxo CEO Sir Andrew Witty issued a statement saying, "Whilst these [actions] originate in a different era for the company, they cannot and will not be ignored. On behalf of GSK, I want to express our regret and reiterate that we have learnt from the mistakes that were made."
Read about two other drug firms that paid huge fines for illegal marketing of psychiatric medications in Psychiatric News.
(image: Rob Byron/Shutterstock.com)